Gambi D - Search Results

1

Prednisone and plasma exchange improve suppressor cell function in chronic inflammatory demyelinating polyneuropathy.

De Luca G, Lugaresi A, Iarlori C, Marzoli F, Di Iorio A, Gambi D, Uncini A. De Luca G, et al. Among authors: gambi d. J Neuroimmunol. 1999 Mar 1;95(1-2):190-4. doi: 10.1016/s0165-5728(98)00266-5. J Neuroimmunol. 1999. PMID: 10229130 Clinical Trial.

2

Interferon beta normalizes suppressor cell function in dysimmune neuropathies.

De Luca G, Lugaresi A, Iarlori C, Marzoli F, Uncini A, Gambi D. De Luca G, et al. Among authors: gambi d. J Neuroimmunol. 1998 Feb;82(1):1-4. doi: 10.1016/S0165-5728(97)00170-7. J Neuroimmunol. 1998. PMID: 9526839

3

Effect of rhTNF-alpha injection into rat sciatic nerve.

Uncini A, Di Muzio A, Di Guglielmo G, De Angelis MV, De Luca G, Lugaresi A, Gambi D. Uncini A, et al. Among authors: gambi d. J Neuroimmunol. 1999 Feb 1;94(1-2):88-94. doi: 10.1016/s0165-5728(98)00229-x. J Neuroimmunol. 1999. PMID: 10376940

4

Chronic inflammatory demyelinating polyneuropathy in diabetics: motor conductions are important in the differential diagnosis with diabetic polyneuropathy.

Uncini A, De Angelis MV, Di Muzio A, Callegarini C, Ciucci G, Antonini G, Lugaresi A, Gambi D. Uncini A, et al. Among authors: gambi d. Clin Neurophysiol. 1999 Apr;110(4):705-11. doi: 10.1016/s1388-2457(98)00028-5. Clin Neurophysiol. 1999. PMID: 10378742

5

RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-beta-1b.

Iarlori C, Reale M, Lugaresi A, De Luca G, Bonanni L, Di Iorio A, Feliciani C, Conti P, Gambi D. Iarlori C, et al. Among authors: gambi d. J Neuroimmunol. 2000 Jul 10;107(1):100-7. doi: 10.1016/s0165-5728(00)00261-7. J Neuroimmunol. 2000. PMID: 10808056

6

Effects of an anti-IL-10 monoclonal antibody on rIFNbeta-1b-mediated immune modulation. Relevance to multiple sclerosis.

Porrini AM, De Luca G, Gambi D, Reder AT. Porrini AM, et al. Among authors: gambi d. J Neuroimmunol. 1998 Jan;81(1-2):109-15. doi: 10.1016/s0165-5728(97)00165-3. J Neuroimmunol. 1998. PMID: 9521612

7

Interferon beta-1b modulates MCP-1 expression and production in relapsing-remitting multiple sclerosis.

Iarlori C, Reale M, De Luca G, Di Iorio A, Feliciani C, Tulli A, Conti P, Gambi D, Lugaresi A. Iarlori C, et al. Among authors: gambi d. J Neuroimmunol. 2002 Feb;123(1-2):170-9. doi: 10.1016/s0165-5728(01)00487-8. J Neuroimmunol. 2002. PMID: 11880161

8

Treatment with an acetylcholinesterase inhibitor in Alzheimer patients modulates the expression and production of the pro-inflammatory and anti-inflammatory cytokines.

Reale M, Iarlori C, Gambi F, Feliciani C, Salone A, Toma L, DeLuca G, Salvatore M, Conti P, Gambi D. Reale M, et al. Among authors: gambi f, gambi d. J Neuroimmunol. 2004 Mar;148(1-2):162-71. doi: 10.1016/j.jneuroim.2003.11.003. J Neuroimmunol. 2004. PMID: 14975597

9

Sensitivity and specificity of diagnostic criteria for conduction block in chronic inflammatory demyelinating polyneuropathy.

Uncini A, Di Muzio A, Sabatelli M, Magi S, Tonali P, Gambi D. Uncini A, et al. Among authors: gambi d. Electroencephalogr Clin Neurophysiol. 1993 Jun;89(3):161-9. doi: 10.1016/0168-5597(93)90129-d. Electroencephalogr Clin Neurophysiol. 1993. PMID: 7686848

10

Low-dose oral methotrexate treatment in chronic progressive multiple sclerosis.

Lugaresi A, Caporale C, Farina D, Marzoli F, Bonanni L, Muraro PA, De Luca G, Iarlori C, Gambi D. Lugaresi A, et al. Among authors: gambi d. Neurol Sci. 2001 Apr;22(2):209-10. doi: 10.1007/s100720170026. Neurol Sci. 2001. PMID: 11603629 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

179 results

Search Page

Filters